Since their initial description nearly half a century ago 1 , research into the characteristics and functions of intermediate filaments (IFs) has solved many important questions pertaining to their assembly mechanisms, structural features, mechanical and biochemical character istics, organization within the cell, biological functions and involvement in many human diseases [2] [3] [4] [5] [6] [7] (see Human IF Mutation Database). As our understanding of IF biology has grown, so has our appreciation for the central role of post-translational modifications (PTMs) in regulating the functional propertie s of IFs.
(see Human IF Mutation Database). As our understanding of IF biology has grown, so has our appreciation for the central role of post-translational modifications (PTMs) in regulating the functional propertie s of IFs.
Studies on IF protein phosphorylation have provided a detailed view of the highly dynamic nature of IF structures and their cell-protective functions, owing to the fact that this PTM regulates IF assembl y and disassembly [8] [9] [10] [11] . Recent research on IF protein sumoyl ation in different species has demonstrated that this type of modification is an evolutionarily conserved mechanism for ensuring the structural and functional integrity of IFs through its ability to regulate IF protein solubility [12] [13] [14] . The role of cellular metabolism in the regulation and function of IFs has been highlighted by examining the glycosylation and acetylation of IF proteins 15, 16 . Furthermore, PTM studies have revealed important interactions between IFs and other cellular components and structures, such as the interaction of 14-3-3 proteins with multiple IFs [17] [18] [19] . Key fundamental and emerging concepts also indicate that modulation of PTMs is a potential mechanism to target defective IF proteins that are a direct cause of, or contribute to, the pathogenesis of neuropathies, myopathies, skin disorders, liver diseases, metabolic dysfunctions and premature ageing syndromes, as well as other diseases 6 . A complete grasp of IF function and dysfunction will require us to understand each IF PTM, including the well-established ones (phosphorylation, glycosylation and prenylation), the newly characterized ones (sumoylation and acetylation) and the putative ones (methylation and malonylation), and to delineate their on-off and crosstalk mechanisms. Given that ~400 different PTMs are catalogued in the UniProt database, of which 107 have been reported in eukaryotes, the functional importance of IF PTMs will remain an important question for years to come.
In this Review, we first introduce IF proteins and then describe the different PTMs that are important for their function. We focus on covalent PTMs (for example, phosphorylation, sumoylation, acetylation, glycosylation and farnesylation), rather than on PTMs that involve protein processing (for example, cleavage by caspases) 20 . The complex crosstalk that occurs between different PTMs on IFs is also considered. Finally, the role of aberrantly modified IF proteins in disease, which underscores the importance of PTMs in regulatin g IF protein function, is discussed.
IFs: the basics of form and function
Owing to their diversity in protein composition and cellspecific presence and functions, IFs are the least characterized of the three major cytoskeletal components; the other two being microfilaments and microtubules. Whereas actins and tubulins, which form microfilaments and microtubules, respectively, have few major subtypes (α, β and γ), there are ~70 different human cell type-specific IF proteins 21 . In further contrast to microfilaments and microtubules, which exhibit structural polarity to enable their cell motility and transport functions, IFs are apolar, flexible structures that provide mechanoprotection and regulate a multitude of cellular growth-and stress-related signalling events 4, 5, 22, 23 . These wide-ranging cellular roles are facilitated by the existence of six major IF protein subtypes (TABLE 1) and two distinct IF systems (one cytoplasmic and one nuclear), each of which is characterized by unique structural and functional features 22 .
Dynamics of IF assembly and disassembly.
All IF proteins share a common three-domain structure that includes an amino-terminal head domain, a carboxy-termina l tail domain and a central α-helical rod domain 2, 4 . Three linker domains (L1, L12 and L2) are interspersed between distinct rod domain sub-helices (coil 1A, coil 1B, coil 2A and coil 2B). There is substantial variability in the amino acid sequences of the globular head and tail domains among the different IF proteins, whereas the rod domains are highly conserved. Cytoplasmic IF proteins exist as obligate homo-or heterodimers as a result of two parallel rod domains that form a coiled-coil structure 24, 25 ( FIG. 1a) . Keratins form obligate type I-type II heterodimers, which is in contrast to many other IF proteins, such as desmin and vimentin, which homodimerize. The association between two vimentin or desmin dimers, in a half-staggered antiparallel manner, produces soluble tetramers, which are the basic cytoplasmic IF subunits in vivo 4 . Further assembly involves lateral association of eight tetramers to form a unit length filament, which is followed by longitudinal annealing of unit length filaments into short filaments, and then radial compaction of the annealed filaments to produce the final 10-11 nm diameter mature IFs 4 (FIG. 1a) . Nuclear lamins have a unique assembly pathway, which begins with rod domainmediate d homodimerization, followed by head-to-tail dimer associations that result in polar polymers and a final lateral joining of the antiparallel polymers to form mature apolar lamin filaments 22, 26 . As the only nuclear IFs, lamins form the nuclear lamina 27 -a complex fibrillar structure located beneath the inner nuclear membrane that also contains lamin-associated proteins. Conversely, cytoplasmic IFs are flexible structures that extend from junctional complexes at the plasma membrane to anchor points at the outer nuclear membrane 22 (FIG. 1b) .
IF structures are highly dynamic, which has been most clearly illustrated in the context of the keratin filament turnover cycle, a process that involves several distinct steps: nucleation of soluble oligomers at the cell periphery, elongation of the smaller particles into short filaments, integration of the short filaments into the peripheral keratin network and, finally, either maturation of the bundled filaments to form a perinuclear cage-like filament structure 28 or disassembly into soluble oligomers which can be used for another cycle 29 . As the intra cellular movement of smaller IF subunits depends on microfilaments, microtubules and molecular motors, drugs that target these systems induce IF re organization 30, 31 . In contrast to microfilaments and micro tubules, there are no known drugs that can directly and specificall y bind to IFs.
Functions of IFs. IF functions are mechanical or nonmechanical in nature 2, 5, 7, 23, 27 . Mechanical functions, as the name implies, support the structural integrity of cells, and the crucial importance of these IF roles is best illustrated by the skin blistering diseases caused by kerati n gene mutations 32 (TABLE 1) . In epidermolysis bullos a simplex (EBS), the first disease to be linked to an IF gene mutation, a disrupted keratin 5 (K5)-K14 filament Mutation of lamin A (LMNA), the gene encoding lamin A and lamin C, results in diseases that are known as laminopathies 36 . This attests to the importance of nonmechanical IF functions, because laminopathies affect numerous physiological processes, including metabolism, skeletal and cardiac muscle function and ageing. As the repertoire of IF functions has grown in recent years, so has our appreciation that many, if not most, of these roles are affected by various PTMs (FIG. 1c; TABLE 2 ).
IF phosphorylation: multifunctional PTM IFs must reorganize and, in some cases, disassemble during physiological and pathophysiological events that change the physical and functional properties of a cell 37, 38 (FIG. 1b) . A general role for IF phosphorylation, which is modulated by numerous kinases and phosphatases 10, 11 (TABLE 2) , is to facilitate IF reorganization by targeting one or more Ser/Thr residues, typically in the head and tail domains. Phosphorylation may also regulate 'dynamic subunit exchange' , whereby new IF subunits can be incorporated anywhere along the length of IF structures 8, 10, 39, 40 . In general, Ser/Thr phosphorylation promotes IF protein solubility, which is a crucial factor in maintaining filament structural dynamics. Our understanding of IF protein Tyr phosphorylation is growing as the number of phosphoproteomic tools increases [41] [42] [43] . Known IF targets for Tyr phosphorylation include K8 (REF. 44 ), K19 (REFS 43, 45) and vimentin 46 . K8 phosphorylation at a highly conserved residue in the rod domain (Tyr267) promotes keratin insolubility and proper filament formation 47 , whereas the effects of Tyr phosphorylation on other IF proteins is poorly understood. The following subsections incorporate established and new evidence that implicates IF phosphorylation in various physiological and disease mechanism s (FIG. 2) .
NF phosphorylation and regulation of axon propertie s. Neurofilaments (NF), which include the light polypeptide (NF-L), the medium polypeptide (NF-M) and the heavy polypeptide (NF-H), were among the first identified IF phosphorylation targets 11, 48 . Although the basal stoichiometry of phosphorylation for most IF proteins is low, NF-M and NF-H are highly phosphorylated basally by Pro-directed kinases on multiple Ser residues located within tail domain Lys-Ser-Pro (KSP) motifs 10, 49 , which is likely to have consequences for axonal calibre, stability and transport 49, 50 . All NF head domains are also phosphorylated but in a transient manner 10 . Moreover, NF head domain and tail domain regulation is highly compartmentalized, such that tail domain phosphorylation through several kinases (TABLE 2) predominates in axons, whereas head domain phosphorylation occurs within neuronal cell bodies 51 . The compartmentalized NF phosphorylation is a tightly regulated process, and dysregulation of NF phosphorylation topography has been implicated in several neurodegenerative diseases 51 . NF tail domain phosphorylation is thought to increase axonal calibre and stability by promoting crossbridging between the lateral projections (side arms) of 24 . Cytoplasmic IFs undergo homo-or heterodimerization. The type III IFs vimentin and desmin undergo homodimerization, which is followed by antiparallel association between homodimers to form soluble tetramers. The further assembly of vimentin and desmin filaments involves lateral association between eight tetramers to form a unit length filament, which is followed by the longitudinal annealing of these into short filaments and radial compaction of the annealed filaments to produce mature IFs 4 . b | IF structures are highly dynamic and reorganize in certain physiological situations, such as during mitosis, and under conditions of cell stress and in response to mutation. Site-specific phosphorylation of head and tail domain residues is a major facilitator of IF reorganization [13] [14] [15] [16] , although other post-translational modifications (PTMs) are also likely to have a role. c | In addition to phosphorylation, IFs undergo several other PTMs that target residues in the head, tail and rod domains, including the α-helical coiled-coils (1A, 1B, 2A and 2B) and the linker regions (L1, L12 and L2). Rod domain PTMs are probably facilitated by head and tail domain PTMs, such as phosphorylation, as indicated by the arrows. The development of PTM-specific IF transgenic mouse models, in combination with important advances in proteomic technologies and antibodies targeted to specific modifications, have accelerated the pace of discovery for novel IF modifications, many of which are altered in the context of disease-causing IF mutants. AcLys, Lys acetylation; C, caspase cleavage; F, farnesylation; Gly, O-linked glycosylation; P, phosphorylation; SUMO, sumoylation; T, transamidation; Ub, ubiquitylation.
interacting NF subunits 10 . There is controversy with respect to the effect of NF phosphorylation on axonal transport, as different methodologies have led to opposing conclusions 52 . For example, the slowest rate of transport was associated with axons that were highly reactive to antibody RT97 (REF. 53 ), which recognizes phosphorylated mouse and human NF-H at KSPXK (X indicates any amino acid) and KSPXXXK motifs in the tail domain 54 . However, ablation of the NF-H C-terminal tail in mice did not alter axonal transport speed 55 , although this might be explained by a compensatory increase in NF-M phosphorylation 52 . Nevertheless, the current model suggests that NF phosphorylation decreases the speed of axonal transport 10, 52, 56 , possibly by promoting NF bundling, which in turn competes with kinesinmediated NF-microtubule association [56] [57] [58] . Determining which kinases phosphorylate which sites in vivo may provide further insight into the importance of NF tail phosphorylation.
IF phosphorylation in stress responses. Reorganization of the IF network is a universal response to stress and has been most extensively studied in the context of keratins 11, 29 . Several transgenic mouse models demonstrate that keratin phosphorylation may act as a phosphate 'sponge' to protect hepatocytes during liver injury. Protection occurs, in part, by shunting phosphorylation away from pro-apoptotic proteins that are themselves activated by phosphorylation 11, 59 . Alteration (through gene mutation) of the major phosphorylation site in the head domain of K8 (Ser74) or K18 (Ser53) increases apoptosis and liver injury in mice expressing the human K8 transgene 59, 60 . Importantly, the effects observed in transgenic mice in which human K8 Ser74 had been substituted with Ala (S74A) are similar to those seen in mice overexpressing a human K8 variant (G62C) that predisposes to liver disease 59 . This suggests that the absence of K8 phosphorylation at Ser74 may predispose humans harbouring the G62C variant to liver disease progression. The phosphorylation motif in K8 that includes Ser74 (LLSPL) is conserved in several type II IFs, including K4, K5 and K6, in which the phosphorylated residue is a Thr (LLTPL). K4, K5 and K6 also undergo phosphorylation at the paralogous sites in response to stress (for example, ultraviolet radiation and apoptosis) or disease (for example, psoriasis and squamous cell carcinoma) 61 . Phosphorylation of K8 Ser74 is mediated by p38 and JUN kinases, which are rapidly activated and recruited to keratin IFs during stress 39, 62, 63 . Following phosphorylation by p38, keratin IFs are disassembled into granules, and this reversible event seems to be necessary for the short-term regulation of epithelial cell plasticity 39 .
IF phosphorylation in viral egress. Mitotic disassembly of lamin A/C, which contributes to the breakdown of the nuclear lamina, is facilitated by phosphorylation of its head domain by cyclin-dependent kinase 1 (CDK1) 64 . Interestingly, this pathway is copied by herpesviruses to facilitate their egress out of the nucleus 65 . Herpesvirus progeny are assembled inside nuclei of infected cells and require an envelopment-de-envelopmen t process to traverse the inner and outer nuclear membranes before the herpesvirus nucleocapsids can be re-envelope d in the cytoplasm. In the absence of lamin phosphorylation, viral access to the nuclear membrane is precluded by an intact nuclear lamina 66 . However, just as CDK1 phosphorylates lamin A at Ser22 to promote its disassembly during mitosis, the viral kinase UL97 phosphorylates this site to promote nuclear lamina disassembly during human cytomegalovirus (HCMV) egress 65 . Phase III clinical trials testing the effectiveness of the UL97-selective inhibitor 1263W94 (Maribavir; ViroPharma) in preventing HCMV infection in liver and haematopoetic stem cell transplant patients were unsuccessful 67 , which suggests that other mediators of lamin disassembly could be involved. For example, the combined kinase activities of viral UL97 and host protein kinase C (PKC) are needed to generate a binding motif (TPLpSPT (p indicates phosphorylation)) for the peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 (PIN1) on lamin A/C 68 . The subsequent PIN1-induced conformational changes in lamin A/C might mediate HCMV egress. Therefore, changes in IF site-specific phosphorylation might regulate the tissue-specific cytopathic effects of various pathogens, in addition to being a general marker of cell stress 7, 11 .
IF phosphorylation in neuromuscular function. Similar to viral egress, a novel nucleocytoplasmic transport mechanism for endogenous ribonucleoprotein (RNP) particles seems to be dependent on the phosphorylation of laminA/C 69 . During Drosophila melanogaster synaptic development, RNP particles that contain synaptic protein transcripts are targeted to the D. melanogaste r A-type lamin Lamin C (LamC). Their nuclear exit follows a mechanism akin to herpesviruses, requiring the activity of atypical PKC and, probably, lamin phosphoryl ation. RNP export was shown to be compromised in D. melanogaster lacking LamC globally or in muscle cells, which resulted in neuromuscular junction (NMJ) defects. Future studies on this pathway in mammalian systems should reveal whether it is regulated by lamin phosphorylation and impaired in laminopathies, which are characterized by neuromuscular deficits.
The potential importance of IF phosphorylation to NMJ function also extends to nestin -a cytoplasmic IF that is expressed during early central nervous system and muscle development 70 . During myoblast differentiation, nestin is phosphorylated at Thr316 by CDK5 in ST15A human neuronal precursor cells, which leads to nestin dissasembly 71 . However, nestin also forms a scaffold for both CDK5 and the CDK5 co-activator p35 (also known as Sororin) in C2C12 mouse myotubes, thus providing a mechanism for continuous regulation of CDK5-p35 activity 70 . Prolonged CDK5 activation, which is enabled after its dissociation from disassembled phosphorylated nestin, is required for acetylcholine (ACh)-induced dispersal of ACh receptor (AChR) clusters 72 . Similar to CDK5-null mice, nestin-null mice exhibit impaired motor coordination and an increased number of AChR clusters in NMJ areas 73 . These investigations demonstrate the importance of IF phosphorylation during neuromuscular development.
In mature myofibres, nestin is downregulated and its expression is replaced by another IF protein, desmin, which also undergoes phosphorylation-mediated depolymerization with in vivo consequences. During fasting-induced muscle atrophy, desmin is phosphorylated in the head domain at Ser28, Ser32 and Ser68. This results in its association with the RING finger ubiquitin ligase tripartite motif-containing 32 (TRIM32) and, ultimately, its disassembly and degradation 74 . This seems to be a crucial event that leads to the breakdown of thin filaments and Z-band components, which highlights an important role for desmin phosphorylation in myofibril destruction during muscle atrophy.
IF phosphorylation in the regulation of cell growth.
Phosphorylation of IFs has long been known to modulate their interactions with IF-associated proteins 75 . The adaptor protein 14-3-3 binds phosphorylated Ser/Thr residues on various protein substrates that, in many cases, contain the motif RSX[pS/pT]XP
76
. The association of several IF proteins, including K5, K17, K18 and vimentin, with 14-3-3 influences cell growth and tumori genesis (FIG. 2) through several mechanisms [17] [18] [19] . K18 was identified as the first 14-3-3 IF-binding partner; their association has been shown to occur during cell cycle progression 77 . K18 phosphorylation at Ser34 in the head domain promotes its solubility and binding to 14-3-3. In mice that overexpress K18-S34A, K8 and K18 filaments in pancreatic acinar cells retract from the basal nuclear region and become apically concentrated, and nuclear retention of 14-3-3 leads to partial mitotic arrest in the liver 18 . In addition, interactions between 14-3-3 and Thr9 and Ser44 of K17 stimulate mTOR activation and cell growth during wound healing in skin epithelia 17 . Elimination of the 14-3-3-binding sites in K17 and K18 increases 14-3-3 nuclear retention, which is associated with decreased mTOR activation, and is probably a mechanism for the observed effects on cell growth 17, 18 . Keratin-14-3-3 mediated modulation of mitosis progression probably involves other pathways, including keratin phosphorylation-mediated regulation of RAF1 binding to 14-3-3 (REF. 78), CDC25 binding to ) and the nuclear distribution of 14-3-3ζ 18 . In addition, 14-3-3 promotes mammary tumorigenesis by stabilizing a soluble K5-K17-actin complex; this function of 14-3-3 is dependent on PKCζ phosphorylation 80 . Maintenance of this complex is thought to facilitate polarized cyto skeletal filament assembly durin g cell migration.
The binding of 14-3-3 to vimentin inhibits autophagy and promotes AKT (also known as PKB)-mediated tumorigenesis of Rat-2 rat fibroblasts 19 . Vimentin is an established marker for e pithelial-to-mesenchymal transition (EMT) 81 , and it is phosphoryl ated by AKT1 at Ser39 (REF. 82); this phosphorylation event promotes in vivo tumour metastasis 82 . Notably, 14-3-3 serves as a linker between phosphorylate d Beclin 1 (a protein required for the initiation of autophagy) and phosphorylated vimentin, and this association promotes autophagy inhibition and tumorigenesis 19 . 93 , which highlights a context-specific function of this phosphorylated residue. Increased cellular elasticity caused by the bioactive lipid sphingosylphosphorylcholine 94 , which was used in the study of pancreatic and gastric cells, probably coordinates a unique migratory programme that is dependent on phosphorylated K8 Ser432-mediated perinuclear filament reorganization of K8 and K18. . This is thought to regulate axonal stability, calibre and transport 52, 53 . Hyperphosphorylated IF aggregates are present in various diseases. In neurodegenerative diseases, hyperphosphorylated NF aggregates are present in neuronal cell bodies, which leads to polarity loss of phosphorylated NFs (pNF) 51 . Phosphorylation of keratin 8 (K8) and K18 protects against apoptosis and hepatotoxicity
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. Phosphorylation of lamin A/C by host and viral kinases facilitates nuclear egress of herpesviruses 65 . A similar nuclear egress mechanism may be used by ribonucleoproteins (RNPs) 69 , although this has not been fully confirmed with respect to the requirement for lamin phosphorylation. Phosphorylation-mediated disassembly of myoblast nestin IFs seems to be important for neuromuscular junction (NMJ) development by facilitating acetylcholine receptor (AChR) dispersal 70 . Fasting-induced desmin phosphorylation leads to its subsequent ubiquitylation and proteasomal degradation, which in turn results in the breakdown of thin filaments to promote muscle atrophy 74 . Phosphorylation of K5, K17, K18 and vimentin facilitates their association with 14-3-3 to promote cellular growth through several mechanisms, including regulation of 14-3-3 localization and its interaction with other proteins, such as the autophagy regulator Beclin 1 80 ). K8 phosphorylation has been shown to both inhibit and promote cell migration, depending on the type of cell and stimulus, whereas vimentin phosphorylation is strongly associated with promoting cell migration 34 . In light of these broad functions of phosphorylation in IF biology, it is noteworthy that changes in IF protein phosphorylation are observed in various human diseases (see below).
Sumoylation: a conserved PTM for IFs
IFs are modified by small ubiquitin-related modifier (SUMO) 95 proteins in a covalent and reversible manner. Conjugation of SUMO (SUMO1, SUMO2 and SUMO3) to mammalian proteins involves the E2 ubiquitin ligase ubiquitin-conjugating enzyme 9 (UBC9), which commonly targets Lys residues within the classic consensus linear motif ΨKX[D/E] (Ψ and X denote a hydrophobic residue and any residue, respectively), although many proteins are modified on Lys residues outside of this motif 95, 96 . SUMO1 is mostly nuclear and conjugated as a monomer, whereas SUMO2 and SUMO3, which are nearly identical in sequence and most probably in function, can be conjugated as polymers to cytoplasmic and nuclear proteins. As discussed below, sumoylation of cytoplasmic and nuclear IFs regulates filament formation and solubility (FIG. 3) , two properties that are markedly altered by disease-causing alterations in IFs, in part owing to sumoylation defects.
Sumoylation of nuclear lamins. The initial evidence that IF proteins were sumoylated came from a yeast two-hybrid screen, which identified UBC9 as an interacting partner of progerin 97 , a truncated version of lamin A that leads to Hutchinson-Gilford progeri a syndrom e (HGPS). It was found later that nuclear levels of UBC9 in HGPS fibroblasts were markedly reduced, which resulted in impaired nucleocyto plasmic protein transport owing to mislocalization of RAN and disruption of the RAN GTPase gradient 98 . Although sumoylation processes are adversely affected by HGPS pathology, it is unknown whether sumoylation of lamin A/C and progerin results in different functional outcomes. The probability that some l aminopathycausing mutants have defective sumoylation was raised by evidence showing that lamin A sumoylation is important for its proper localization 14 . However, the relationship between sumoylation and the various laminopathies remains correlative at this point, as nearly every known lamin mutant results in disease.
Lamin A is monosumoylated by SUMO2 at the highly conserved rod-domain residue Lys201, which is part of a SUMO consensus motif (MKEE) 14 . Alterations within this motif (K201R, E203G and E203K) eliminate lamin A sumoylation and result in large lamin A puncta inside the nucleus or at the nuclear periphery (FIG. 3a) . These findings suggest that defective lamin A sumoylation could possibly contribute to the pathogenesis of dilated cardiomyopathy (DCM) in patients carrying lamin A E203G and E203K mutants 99 . Similarly, several DCM-causing lamin A mutants (D192G, Q353K and R386K) formed SUMO1-containing aggregates 99 . As these mutants also increased overall nuclear protein sumoylation, it is possible that the sequestered SUMO1 may have been conjugated to other proteins, to which access by desumoylases may have been prevented by the aggregates. In small ubiquitin-related modifier (SUMO)-null worms, IFB-1 filaments seem to be a heterogeneous population of different sized aggregates, long filaments and ring-like structures; the occurrence of large aggregates increases with age 12 . Similarly, sumoylation at Lys201 in the highly conserved rod domain of human lamin A is important for its proper nuclear localization 14 . The sumoylationdeficien t lamin A mutants K201R, E203G and E203K form abnormal puncta inside the nuclei or at the nuclear periphery 14 . Laminopathy-associated lamin A mutants, as exemplified by those listed in the figure, are hyposumoylated and exhibit abnormal organization in comparison with normal lamin A 14, 99 . b | Sumoylation regulates the solubility of IFs. Sumoylation sequesters a fraction of IFB-1 into a soluble cytoplasmic pool and facilitates the exchange between the soluble and polymerized IFB-1 pool 12 . Sumoylation of wild-type polymerized human keratin 8 (K8) and K18 (depicted by the blue filaments in the middle) is not readily detectable under basal conditions, but it is highly upregulated during the reorganization of these IFs in response to apoptosis, stress, disease or in the context of K8 variants that predispose to liver disease 13 . Monosumoylation promotes K8 solubility in vitro, similar to IFB-1, whereas pathological hypersumoylation is associated with diminished K8 solubility and formation of high-molecular mass complexes 13 .
Familial partial lipodystrophy
A metabolic disorder that involves abnormal distribution of subcutaneous adipose tissue and can also lead to insulin-resistant diabetes.
Hemidesmosome
A cell-to-substrate attachment site that contains keratin IFs, plectin and α6β4 integrin, among other proteins that bind to extracellular matrix components, such as laminin 5 and type VII collagen.
Alexander disease (AxD). A rare early-onset neurodegenerative disease that involves destruction of myelin and is caused by mutations in the gene encoding glial fibrillary acidic protein (GFAP).
Lys420 and Lys486 in the tail domain of lamin A are direct SUMO1 targets 100 , and the lamin A mutants G465D and K486N, which cause familial partial lipodystroph y, are deficient in SUMO1 conjugation 100 . Whereas Lys420 of lamin A is nested within a linear SUMO consensus motif, Lys486, which is located within the immunoglobulin-like fold, is not. It was proposed that Lys486 sumoylation becomes enabled by a consensus 'patch' of several acidic residues, which formed a three-dimensional UBC9-recognition site 100 . Loss of this putative UBC9-recognition site may be the reaso n for the lack of sumoylation in the G465D mutant, as it localizes within the immunoglobulin-like fold. Interestingly, sumoylation of the immunoglobulin-like fold in lamin A may reflect an evolutionarily conserved process for modulating the properties of this domain, based on studies of the Caenorhabditis elegans IF B1 (IFB-1) 12 .
Sumoylation of cytoplasmic IFs. C. elegans IFB-1 is functionally similar to epidermal keratins 12, 101 , although it contains an immunoglobulin-like fold that is similar to vertebrate nuclear lamins. During embryonic development, IFB-1 is required for elongation. During post-embryonic development, IFB-1 provides a h emidesmosome-like mechanical linkage between muscle and the cuticle, an exoskeleton that is composed of a collagenous extracellular matrix. The normal organization of IFB-1 is a striped pattern of filaments along the basal and apical membrane of the epidermis. By contrast, SUMO-null worms exhibit ectopic circular and long filaments and cytoplasmic inclusions of various size and morphology that increase with age 12 (FIG. 3a) .
These abnormalities were attributed to a decrease in IFB-1 solubility in the absence of sumoylation at Lys460 (REF. 12) (FIG. 3b) . A reduction in the levels of soluble IFB-1 that was available for exchange with the polymerized IFB-1 pool caused embryonic elongation defects, thus providing evidence that IF solubility is of physiological importance and prompting investigation into the effects of sumoylatio n on mammalian cytoplasmic IFs.
Human keratins (K5, K8, K14, K18 and K19) and vimentin are extensively and preferentially modified by SUMO2 and SUMO3 over SUMO1 in vitro 13 . The modification of K8, K18 and K19 by SUMO2 or SUMO3 chains occurs on multiple conserved rod domain sites within consensus motifs, including at Lys207 in K18 and at Lys208 in K19, which are paralogues of the SUMO2 target Lys201 on lamin A. In contrast to lamin A sumoylation, keratin sumoylation was not detected under basal conditions. However, the induction of filament reorganization by oxidative and apoptotic stress or hyperphosphorylation greatly upregulated keratin sumoylation 13 . Findings in mouse and human chronic liver injury supported the stress-induced mode of keratin sumoylation, whereas in vitro evidence suggested that keratin monosumoylation increases keratin solubility, but hypersumoylation decreases it 13 (FIG. 3b) .
Together with the findings on IFB-1, these data indicate that the role of SUMO in regulating the solubility of cytoplasmic IFs is evolutionarily conserved.
From a human disease perspective, the most commonly known K8 variants that predispose individuals to acute and chronic liver disease progression (G62C and R341H) 102, 103 have decreased solubility and are extensively sumoylated under basal conditions 13 . Mutationinduced conformational changes may facilitate access of SUMO and its ligases to the keratin rod domains under basal conditions. The decreased solubility probably compromises the dynamics of mutant keratin filaments by limiting the substrate availability for the nucleation step of the keratin cycle 29 .
In addition to its role in the liver, K8 is also essential for the integrity of the intestinal epithelium, as K8-null mice develop colitis, hyperplasia, diarrhoea and show aberrant targeting of apical and basolateral proteins 104 . Interestingly, inducible UBC9-null mice also display a profound loss of basoapical enterocyte polarity and enterocyte detachment from the basal lamina 105 a pheno type that is reminiscent of tissue fragility disorders due to keratin loss or dysfunction 32 . Loss of K8 sumoylation was proposed as one potential mechanism for the compromised enterocyte integrity in adult mice lacking UBC9 (REF. 105 ). Therefore, regulated sumoylation seems to be essential for keratins in digestive epitheli a, and this probably extends to other IFs.
IF Lys acetylation: a metabolic sensor
Conventionally regarded as a modification for histones and microtubules, Lys acetylation is now known to regulate many other proteins. IF proteins are among ~1,000-1,700 acetylation targets, based on identification of their putative acetylation sites through large-scale studies 106, 107 . Validation of these sites and delineation of their context-specific functions will take time as new tools (for example, site-specific acetyl-Lys antibodies 108 ) for studying this modification are currently being developed and refined. Based on the evidence to date, Lys acetylation seems to modulate IF properties in response to metabolic changes 16 . A conserved Lys residue (Lys207) in the rod domain of K8 was identified as a putative acetylation target by mass spectrometry 106, 107 and was confirmed as a functionally important K8 acetylation site 16 . Basal acetylation at Lys207 reduces K8 solubility and promotes the formation of a dense perinuclear K8 filament network. Increased K8 acetylation is observed during hyperglycaemia and during inhibition of the NAD-dependent deacetylase sirtuin 2 (SIRT2). This is accompanied with changes in K8 biochemical and filament properties 16 , including K8 oligomerization and the formation of perinuclear aggregates in a subset of cells. Therefore, SIRT2 is likely to be a broad regulator of the cytoskeleton, as it is also an α-tubulin deacetylase 109 . A survey of published data 106 and datasets curated by the bioinformatics resource PhosphoSitePlus 110 reveals that sites mutated in IF diseases, including Lys97 of lamin A (K97E in DCM 111 ) and Lys86 of glial fibrillary acidic protein (GFAP; K86E in Alexander disease (AxD) 112 ), might be acetylated. The change from a positively charged Lys to a negatively charged Glu in each case suggests that the charge at this site, which would
Amyotrophic lateral sclerosis
A progressive neurodegenerative disease, affecting motor neurons, which is mostly sporadic and caused by mutations in less than 10% of cases.
be neutralized by the addition of an acetyl group to the Lys, is probably an important determinant of filament properties. Furthermore, the end of coil 1A in K5, which is a mutation 'hot spot' for EBS 32 , contains two putative acetylation sites (Lys178 and Lys185). It remains to be determined whether these are bona fide acetylation sites and whether defective acetylation is involved in the pathogenesis of these K5 variants. 15 , which demonstrates the difficulties in studying this modification. Nevertheless, it is clear that K18 glycosylation at three residues in the head domain (Ser30, Ser31 and Ser49) helps to protect epithelial cells from injury 15 . Mice that overexpress glycosylation-deficient human K18 show increased susceptibility to liver and pancreatic injury induced by streptozotocin, which inhibits O-GlcNAcase. The underlying mechanism involves decreased phosphorylation of AKT1 and PKCθ (at sites that are crucial for their kinase activities) when K18 glycosylation is disabled 15 . AKT1 phosphorylation at Thr308, which is critical for its cell survival function, is dependent on both its direct association with the K18 heterodimeric partner K8 as well as K18 glycosylation 15 . Hence, it seems that a major role for keratin glycosylation in simple-type epithelia is to facilitate the phosphorylation and activation of cell survival kinases during stress and injury.
O-linked glycosylation of IFs
The functional role of NF glycosylation is less clear, although it is known to be dynamically regulated by meta bolic changes. NF-L glycosylation occurs at Thr21 and Ser27 in the head domain 118 , and NF-M glycosylation occurs at Thr48 in the head domain and at Thr431 in the tail domain 120 . Additional NF-M glycosylation sites are present based on the fact that the tail domain of NF-M, which cannot be glycosylated at Thr431, still reacts to an antibody (NL6) that detects glycosylation 121 .
The amount of glycosylated NF-M, which is highest in human axons, is decreased in brains from patients with Alzheimer's disease 122 . Animal models further support a metabolically linked and pathological decrease in NF-M glycosylation, as NF-M glycosylation was decreased in fasting rats 122 and in a rat model of amyotrophic latera l sclerosis 121 . In contrast to NF-M glycosylation, NF-H glycosylation is increased in response to glucose deprivation, owing to an increase in OGT activity, which is dependent on AMP-activated protein kinase (AMPK) 123 . It remains to be determined whether the reported differ ences in NF-H and NF-M glycosylation are non-enzymat ic, technical in nature (glycosylation is altered in post-mortem tissue 121 ) or rooted in different biological mechanisms. The functional importance of NF glycosyl ation and glyco sylation of other IFs awaits further investigation and the development of better tools to study this important modification.
Farnesylation of nuclear lamins
Nuclear A-and B-type lamins are modified by farnesylation; this is a type of prenylation that invloves the modification of proteins with lipid intermediates from the cholesterol biosynthesis pathway 124 . Farnesylation of normal lamin A by farnesyltransferase (FTase) is transient and thought to facilitate its initial association with the inner nuclear membrane through hydro phobic interactions 27 . Full maturation of lamin A requires proteolytic removal of 15 tail domain residues, including farnesylated Cys, by zinc metalloproteinase Ste24 homologue (ZMPSTE24) 27 . Progerin does not undergo this last step, because it lacks the ZMPSTE24 internal cleavage site and thus becomes permanently associated with the inner nuclear membrane. This is considered to be the major underlying mechanism in the pathology of HGPS, which has been targeted by FTase inhibitors (FTIs) in recent clinical trials
B-type lamins (which are encoded by two different genes, LMNB1 and LMNB2) are processed in a similar manner to lamin A/C, except they do not undergo the last cleavage step and they therefore permanently retain their farnesyl lipid anchor. Knock-in mice expressing non-farnesylatable lamin B2 seem to develop in a normal manner, whereas lamin B1 that cannot be farnesylated results in severe impairment in neuronal development and perinatal death 125 . At the cellular level, non-farnesylated lamin B1 displays an abnormal 'honeycomb' pattern of nuclear distribution in mouse embryonic fibroblasts and leads to nuclear blebbing and chromatin detachment from the nuclear lamina in neurons 125 . Of note, treatment of normal human fibroblasts with FTIs disrupts lamin B processing by decreasing the levels of mature lamin B1 and causing accumulation of unprocessed lamin B2 in the nucleoplasm 126 . The numerous studies on lamin farnesylation have provided strong evidence for the importance of this IF modificatio n in cellular function and organismal development.
Modification of IFs by other PTMs
PTMs in addition to those already discussed can modify IF proteins. However, the mechanics of these modifications with respect to IFs and their functions are just beginning to emerge.
Ubiquitylation. The obligatory nature of keratin heterodimers suggests that either keratin monomer might be degraded by the ubiquitin-proteasome system in the absence of its partner, which usually provides a stabilizing Nature Reviews | Molecular Cell Biology [127] [128] [129] . Various E2 ubiquitin ligases, including UBC3 (also known as CDC34), UBC5, UBC homologue 5 (UBCH5; also known as UBE2D1) and UBC6 (also known as UBE2J1), are required for keratin degradation in response to mechanical stress and hypoxia, presumably as a stress adaptation mechanism 128 . Whereas the ubiquitin ligase C terminus of HSP70-interacting protein (CHIP; also known as STUB1) seems to target mutant keratins for degradation 130 , ubiquitylation sites on IF proteins are not known aside from putative Lys residue s identified through mass spectrometry 131 . Many IF-associated diseases, including myopathies, neuropathies and liver diseases are characterized by IF-containing aggregates that include ubiquitin 102, 132, 133 .
Normal nucleus Progeria nucleus
In AxD mouse models, dissolution of GFAP aggregates into smaller oligomers and monomers, mediated by the small heat shock protein αβ-crystallin, results in improved proteasomal clearance of the mutant GFAP, with reduced brain defects and mortality 134, 135 . Furthermore, a mouse progeroid phenotype involves the selective ubiquitylation and proteasomal degradation of mature lamin A. This is facilitated by its interaction with the E3 ubiquitin ligase seven in absentia homologue 1 (SIAH1), which does not bind lamin C or progerin 136 . Therefore, ubiquitylation of IF proteins is a normal physio logical process that is involved in IF turnover, whereas accumulation of ubiquitylated IF proteins occurs in the context of cellular dysfunction that is accompanied by proteasome inhibition.
Transamidation. The activity of transglutaminase 2 (TGase 2) -an inducible acyltransferase that catalyses the formation of amide bonds (transamidation) between the ε-N group of Lys and the γ-C group of Gln -regulate s IF function under physiological and pathological contexts. Transamidation seems to be essential for the attachment of several epidermal type II keratins to the cornified envelope of the skin, which provides a crucial barrier function 137 . In the setting of certain chronic liver diseases, most commonly alcoholic and non-alcoholic steatohepatitis, K8 in hepatocytes becomes crosslinked by TGase 2 (REF. 138 ), which results in the formation of K8-K18 aggregates termed Mallory-Denk bodies (MDBs); these also contain ubiquitin and the u biquitin-binding protein sequestosome 1 (SQSTM1; also known as p62) (REF. 139 ). The first, of probably multiple, transamidation sites on K8 was recently identified as Gln70 in the head domain 140 . A major challenge is to identify other relevant IF protein transamidation targets and sites in vivo, which will undoubtedly require the development of new methods to study this modification, as it is not routinely evaluated by mass spectrometry. Examining multiple potential TGase 2 mechanisms will also be essential. For example, neuronal tubulin undergoes TGase 2-mediated poly amination -a covalent conjugation to polyamines such as putrescine, spermidine and spermine -which decreases tubulin solubility and is likely to aid the formation of stable axonal microtubules 141 . Such future studies will probably provide important mechanistic insights into protein aggregation mechanisms in the liver and other tissues (for example, brain and muscle) that are known to harbour pathological IF inclusions.
ADP-ribosylation.
The type III IFs desmin and vimentin undergo covalent modification with ADP-ribose; this process is catalysed by different enzymes but
Box 1 | Targeting defective lamin A prenylation in the clinic
Therapeutic strategies have been developed to target the defective prenylation of lamin A seen in Hutchinson-Gilford progeria syndrome (HGPS). The main distinguishing feature between lamin A and progerin, which is the HGPS truncated mutant (C1824T) form of lamin A, is the permanent farnesylation of progerin. This prevents its release from the inner nuclear membrane, which results in severe abnormalities in nuclear morphology and function 169 . Farnesylation is the modification of proteins with lipid intermediates from the cholesterol biosynthesis pathway 124 . Farnesylation of normal lamin A by farnesyltransferase (FTase) is transient and thought to facilitate its initial association with the inner nuclear membrane through hydrophobic interactions 27 (see the figure; left). Full maturation of lamin A requires proteolytic removal of 15 tail domain residues, including the Cys residue that is farnesylated by zinc metalloproteinase Ste24 homologue (ZMPSTE24) 27 . Progerin does not undergo this last step, because it lacks the ZMPSTE24 internal cleavage site and thus becomes permanently associated with the inner nuclear membrane (see the figure; right). Dashed arrows indicate an indirect process. For a detailed overview of lamin processing, see REF. 27 .
Farnesyltransferase inhibition in HGPS
The establishment of persistent farnesylation as being, at least partly, responsible for the HGPS phenotype formed the basis for the potential use of FTase inhibitors (FTIs) to potentially treat HGPS 168 . FTIs alleviated the characteristic nuclear morphology defects in progerin-expressing cells and extended lifespan while improving weight gain and cardiovascular function in HGPS mouse models 169 . Given that patients with HGPS die (at an average age of 13 years) of a heart attack or stroke, and that FTIs have a favourable safety profile in humans, 25 patients with HGPS were enrolled in a multi-year prospective single-group Phase II clinical trial of the FTI lonafarnib (Sarasar; Schering-Plough Corporation) 165 . The results of this initial trial revealed varied success with respect to the primary outcome (weight gain) but significant improvements in secondary outcomes (vascular stiffness, bone structure and hearing). New insights from basic research should help to inform potential future studies in patients using combination therapy. 
Steatohepatitis
Inflammation and fat accumulation in the liver that is most frequently triggered by alcohol consumption or obesity.
with similar functional outcomes. Vimentin is ADPribosylated in vitro by bacterial SpyA 142 , and the same reaction in desmin is facilitated by endogenous muscle ADP-ribosyltransferase 143, 144 . In each case, head domain Arg residues are modified, which inhibits filament formation. In the case of desmin, the presence of phosphates is crucial for the assembly defect, because ribosylated desmin retains filament-forming capabilities. The physiological importance of this IF modification remains to be defined.
Putative IF modifications. Lys methylation 145, 146 , Lys malonylation 147 , and Arg mono-and dimethylation 148 have been identified as putative PTMs of IF proteins through large-scale mass spectrometry studies but await experimental validation and functional assessment.
PTM crosstalk and IF proteins
Various PTMs participate in complex crosstalk to regulate the properties and cellular function of proteins at a global level 113, 149, 150 . As new modifications of IFs are identified and characterized, the next challenge is to consolidate the evidence and construct a cohesive portrait of their combined effects. Phosphorylation and sumoylation. Sumoylation of keratin IFs is strongly increased by phosphorylation. Treatment with the phosphatase inhibitor okadaic acid induces keratin hyperphosphorylation, with a concomitant increase in sumoylation 13 . In the case of K8, this is partially dependent on phosphorylation at Ser74 (a stress-sensitive site), which, by promoting filament re organization, presumably facilitates access of the sumoylation machinery to Lys285 and Lys364 of the K8 coil 2 domain. It is also plausible that putative phosphorylation sites in coil 2 and the preceding L12 domain of K8, which have been identified by largescale studies 151, 152 but have not been confirmed experimentally, affect K8 sumoylation more directly. As the stress-protective functions of keratins are intimately tied to their ability to undergo site-specific phosphorylation 59 , exactly how phosphorylation modulates the sumoylation of keratins and other IFs remains an important avenue to explore in future studies.
Phosphorylation and glycosylation.
Similar to what has been reported for other proteins 113 , there seems to be an inverse correlation between phosphorylation and glycosylation of NFs and keratins. Ageing-related decline in the expression and activity of protein phosphatase 2A (PP2A) is related to NF-H hyperphosphorylation at tail domain KSP repeats 153 . Furthermore, a similar increase in NF-M phosphorylation is observed in brains from patients with Alzheimer's disease, which is paralleled by a decrease in NF-M glycosylation 122 . As this effect was also observed in the brains of fasting rats, it has been postulated that Alzheimer's disease-associated impairments of glucose uptake and metabolism lead to NF-M hypoglycosylation 122 . A similar inverse relationship between phosphorylation and glycosylation is observed for keratins in the context of mouse liver injury 154 . Mechanistic studies examining the effects of IF phosphorylation on glycosylation, and vice versa, are needed to reveal whether the two pathways regulate each other. K18 glycosylation occurs independently of phosphorylation in the head domain of K18 15 . However, blockade of K18 glycosylation leads to an increase in the phosphorylation of its partner, K8, at Ser74 (REF. 15 ). As AKT1 directly binds to K8 and AKT1 phosphorylation is crucially modulated by the glycosylation status of K18 (REF. 15 ), this may reflect a signalling hub for complex PTM crosstalk between modifications on three closely interacting proteins.
Phosphorylation and acetylation. K8 Lys acetylation may function as a sensor to link metabolic status to K8 phosphorylation and filament reorganization. Keratin filaments greatly reorganize in response to metabolic Phosphorylation also regulates the interaction of lamins with lamin-associated proteins, including transcription factors and other lamin binding partners 171, 172 . Lys acetylation (Ac), phosphorylation and ubiquitylation (Ub) regulate IF filament formation, disassembly and turnover in response to physiological and pathophysiological cellular changes. Functional inhibition of IFs under severe cellular stress is mediated by IF crosslinking and aggregation through transamidation and polyubiquitylation. b | Crosstalk between IF PTMs (the plus signs indicate where one PTM promotes another). There is a reciprocal regulation between phosphorylation and glycosylation of neurofilaments (NFs) and keratins. Hyperphosphorylation and hypoglycosylation of NFs are observed in neurodegeneration and ageing, whereas keratin 18 (K18) hypoglycosylation leads to hyperphosphorylation of its partner, K8, during epithelial cell injury. Stress-induced keratin phosphorylation is limited in the absence of basal acetylation 16 . Ubiquitylation is frequently observed on hyperphosphorylated IFs 127 and is associated with proteasomal inhibition 134 . Transamidation, which involves isopeptide bond formation between Lys and Gln, is facilitated by phosphorylation of keratin IFs 140 . Sumoylation of keratin IFs is strongly increased in the presence of phosphorylation 13 , which may facilitate IF rod domain access to SUMO proteins and ligases through its ability to induce filament reorganization. Whereas there is ample evidence for IF PTM cross regulation, the exact mechanisms and regulators remain to be determined. stress, such as autophagy inhibition, in which K8 undergoes aggregation in a Ser74 phosphorylation-mediated manner 155 . As already discussed, this residue is an important stress-induced K8 phosphorylation site that is phosphorylated by p38 and JUN kinases to shape the keratin filament cytoskeleton through increasing K8 solubility 39, 62, 63, 156 . By contrast, acetylation at Lys207 of K8 under basal conditions promotes insolubility, and blocking Lys207 acetylation greatly reduces phosphorylation of K8 at Ser74 (REF. 16 ). The mechanism for this remains to be addressed, including the possibility that acetylation may facilitate the recruitment of p38 or other kinases to K8.
Phosphorylation, ubiquitylation and transamidation.
Ubiquitylation is frequently observed in the context of hyperphosphorylated IFs 127 . The mechanistic connection between phosphorylation and ubiquitylation requires further study, but it is possible that site-specific IF phosphorylation participates in the recruitment of ubiquitin ligases. IF protein ubiquitylation is also associated with proteasomal inhibition 134 49, 160 , lamins 157 and keratins 102, 159, 161 . Moreover, aggregates of hyperphosphorylated NFs are found in the soma of neurons, which is in contrast to their exclusive presence in axons under normal conditions 51 . It was demonstrated that PIN1 isomerase blocks dephosphorylation of NFs and that PIN1 inhibition may be a potential strategy to prevent aberrant NF hyperphosphorylation in neurodegenerative diseases 162 . Future translational studies may be aimed at modulating NF and other IF domain-specific phosphorylation changes.
Phosphorylation at Tyr residues of IFs may also mediate some disease mechanisms. Alteration of the highly conserved phosphotyrosine, Tyr267, in the K8 rod domain and of the paralogous residue on GFAP (Tyr242) leads to defective filament formation in each case 47 . Of note, GFAP Tyr242 is mutated in AxD (Y242D) and its proximity to Arg239, the most common AxD GFAP alteration site 133 , raises the possibility that disease-causing alterations in GFAP may lead to aberrant phosphorylation.
Vast advances in proteomic capabilities may facilitate 'finger-printing' of IF PTMs as potential disease biomarkers 163 . One advantage that IFs offer over many other proteins in this regard is their cellular abundance. In addition, targeting IF PTMs is a potential avenue for de vising therapeutic strategies to overcome the detrimental effects of IF gene mutations. The first bench-to-bedsid e example of this is the recently concluded Phase II clinical trial targeting the aberrant farnesylation of progerin in HGPS with the FTI lonafarnib (Sarasar; Schering-Plough Corporation) 164, 165 
. The study provided a clinical example of the fact that pharmacological targeting of an aberrantly modified IF protein can be used as a potential treatment of human disease.
Conclusion and perspective
The importance of PTMs in the function of the IF cytoskeleton is evident from several perspectives. With respect to normal cellular physiology, PTMs regulate IF organization and the binding of IFs to IF-associated proteins, which consequently regulates numerous cellular processes and cell-specific functions. Many human diseases are marked by important changes in IF PTMs. These changes may be caused or aggravated by an IF gene mutation, or may simply be related to the stress or patho genesis of the disease and the pathological condition resulting from it, independent of an IF gene mutation. In principle, it is possible that alterations in disease-associated IF PTMs might protect against the disease pathology or perpetuate the disease and its manifestations, thus providing a potentia l treatment target.
There are several crucial areas that warrant extensive future studies with regard to IF PTMs. The first is to experimentally validate large-scale proteomic data and ascribe functions to the different IF modifications. The second is to define the physical and temporal relationship and crosstalk between the various types of PTMs, particularly given that the same residue can undergo more than one PTM. The third is to characterize the onoff enzymatic machinery behind the various IF modifications. The fourth is to evaluate the PTM signature of disease-causing IF mutants, compared with normal IFs, as potential biomarkers. The fifth is to assess the suitability of IF PTMs as potential therapeutic targets. From a human health perspective, the latter two areas may offer exciting opportunities. For example, antibodies against specific aberrant PTMs could be used as effective diagnostic and prognostic tools. Furthermore, results of the use of kinase inhibitors such as selumetinib (AZD6244; AstraZeneca) in cardiomyopathy animal models 166 and muscular dystrophy 167 , caused by mutation in the gene encoding lamin A/C, provide a promising proof-of-princip le for the use of PTM targeting in disease.
